lutein has been researched along with Cancer of Liver in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Kumar, R; Maradagi, T; Ponesakki, G | 1 |
Baraya, YS; Wong, KK; Yaacob, NS; Yankuzo, HM | 1 |
Jordão, A; Moreno, FS; Ong, TP; Pinho, AL; Toledo, LP; Vanucchi, H | 1 |
Gao, YT; Ong, CN; Ross, RK; Yu, MC; Yuan, JM | 1 |
4 other study(ies) available for lutein and Cancer of Liver
Article | Year |
---|---|
Hyperglycaemia-induced human hepatocellular carcinoma (HepG2) cell proliferation through ROS-mediated P38 activation is effectively inhibited by a xanthophyll carotenoid, lutein.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Hep G2 Cells; Humans; Hyperglycemia; Liver Neoplasms; Lutein; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Xanthophylls | 2022 |
Strobilanthes crispus bioactive subfraction inhibits tumor progression and improves hematological and morphological parameters in mouse mammary carcinoma model.
Topics: Acanthaceae; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Female; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lutein; Mice, Inbred BALB C; Plant Extracts; Sitosterols; Splenic Neoplasms; Tumor Burden | 2021 |
Inhibitory effects of lutein and lycopene on placental glutathione S-transferase-positive preneoplastic lesions and DNA strand breakage induced in Wistar rats by the resistant hepatocyte model of hepatocarcinogenesis.
Topics: Animals; Anticarcinogenic Agents; Carotenoids; Comet Assay; DNA Damage; Glutathione Transferase; Hepatocytes; Hydrogen Peroxide; Liver; Liver Neoplasms; Lutein; Lycopene; Male; Placenta; Precancerous Conditions; Rats; Rats, Wistar | 2003 |
Prediagnostic level of serum retinol in relation to reduced risk of hepatocellular carcinoma.
Topics: beta Carotene; Carcinoma, Hepatocellular; Carotenoids; Case-Control Studies; China; Cryptoxanthins; Humans; Incidence; Liver Neoplasms; Logistic Models; Lutein; Lycopene; Male; Micronutrients; Middle Aged; Odds Ratio; Prospective Studies; Risk Assessment; Risk Factors; Selenium; Tocopherols; Vitamin A; Xanthophylls; Zeaxanthins | 2006 |